ArticleClinical rheumatology2010

An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX).

Norma Jung et al.PubMed ↗Publisher ↗

No numbers read from the abstract.